Transverse myelitis historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (4 intermediate revisions by one other user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948. Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and [[smallpox]] vaccination. | |||
==Historical Perspective== | ==Historical Perspective== | ||
| Line 11: | Line 13: | ||
*Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948.<ref name="pmid28798719">{{cite journal| author=Hsam NBO, Angstwurm K, Peters S, Fuchs K, Schuierer G, Bogdahn U | display-authors=etal| title=Fulminant Acute Ascending Hemorrhagic Myelitis Treated with Eculizumab. | journal=Front Neurol | year= 2017 | volume= 8 | issue= | pages= 345 | pmid=28798719 | doi=10.3389/fneur.2017.00345 | pmc=5529383 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28798719 }} </ref> | *Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948.<ref name="pmid28798719">{{cite journal| author=Hsam NBO, Angstwurm K, Peters S, Fuchs K, Schuierer G, Bogdahn U | display-authors=etal| title=Fulminant Acute Ascending Hemorrhagic Myelitis Treated with Eculizumab. | journal=Front Neurol | year= 2017 | volume= 8 | issue= | pages= 345 | pmid=28798719 | doi=10.3389/fneur.2017.00345 | pmc=5529383 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28798719 }} </ref> | ||
*Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and [[smallpox]] vaccination. | *Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and [[smallpox]] vaccination.<ref name="pmid15956176">{{cite journal| author=Krishnan C, Kerr DA| title=Idiopathic transverse myelitis. | journal=Arch Neurol | year= 2005 | volume= 62 | issue= 6 | pages= 1011-3 | pmid=15956176 | doi=10.1001/archneur.62.6.1011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15956176 }} </ref> | ||
=== | |||
=== | |||
=== | |||
==References== | ==References== | ||
Latest revision as of 19:49, 7 July 2020
|
Transverse myelitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Transverse myelitis historical perspective On the Web |
|
American Roentgen Ray Society Images of Transverse myelitis historical perspective |
|
Risk calculators and risk factors for Transverse myelitis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948. Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and smallpox vaccination.
Historical Perspective
Discovery
- Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948.[1]
- Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and smallpox vaccination.[2]
References
- ↑ Hsam NBO, Angstwurm K, Peters S, Fuchs K, Schuierer G, Bogdahn U; et al. (2017). "Fulminant Acute Ascending Hemorrhagic Myelitis Treated with Eculizumab". Front Neurol. 8: 345. doi:10.3389/fneur.2017.00345. PMC 5529383. PMID 28798719.
- ↑ Krishnan C, Kerr DA (2005). "Idiopathic transverse myelitis". Arch Neurol. 62 (6): 1011–3. doi:10.1001/archneur.62.6.1011. PMID 15956176.